NCT03319095

Brief Summary

It is estimated that about 30% of women cannot voluntarily contract the pelvic floor muscles (PFM). PFM training (PFMT) represents the first therapeutic option for the treatment of female urinary incontinence (UI), however the inability to contract this muscle makes PFMT unfeasible. The primary objective of this project is to evaluate clinically the efficacy of intravaginal electrical stimulation associated with verbal instructions to provide the ability of women to contract voluntary their PFM. The secondary objective is to evaluate the UI prevalence and impact on quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 19, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 24, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

December 12, 2017

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 6, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 6, 2020

Completed
Last Updated

June 18, 2020

Status Verified

June 1, 2020

Enrollment Period

2.2 years

First QC Date

October 19, 2017

Last Update Submit

June 16, 2020

Conditions

Keywords

pelvic floor, muscle, electrical stimulation, physiotherapy

Outcome Measures

Primary Outcomes (1)

  • Bidigital Vaginal Palpation

    The primary outcome will be assessed by bidigital vaginal palpation using the modified Oxford scale at baseline and after 10 weeks. The correct contraction of the PFM will be considered as the action of occlusion and elevation of the PFM around the examiner's fingers in the ventral and cranial directions. Therefore, it will be considered a clinically relevant improvement to obtain a score above 3 on the modified Oxford scale. The examination will be performed following the following steps: * The participant will receive information about the procedure, and basic anatomy of the PFM. * She will be placed in dorsal decubitus, with hips and knees flexed, feet supported and legs apart; * The examiner using a procedure glove will carefully insert the index and middle fingers into the vaginal canal; * The participant will be instructed to contract the PFM in order to raise and compress the examiner's fingers. * To conclude, the participant will be directed to completely relax the PFM.

    30 minutes

Secondary Outcomes (1)

  • International Consultation on Incontinence Questionnaire - Short Form (ICIQ-SF)

    20 minutes

Study Arms (2)

Control

NO INTERVENTION

Control group: participants will receive only verbal instructions on PFM anatomy and function during the first assessment when women will be required to contract their pelvic floor muscle. The participants will have no contact with the service until the second assessment

Intervention

ACTIVE COMPARATOR

Intravaginal Electrical Nerve Stimulation: participants will be submitted to Intravaginal Electrical Nerve Stimulation

Device: Intravaginal Electrical Nerve Stimulation

Interventions

The Intervention group will receive Intravaginal Electrical Nerve Stimulation using Quark® Dualpex equipment, once per week during 8 weeks. The selected current will be biphasic, and the stimulation parameters will be: 50 Hz frequency, pulse width of 200 microseconds, contraction time (Ton) of 5 seconds, relaxation time (Toff) of 10 seconds, intensity of current defined according to the sensitivity (tolerance) of the patient, and total stimulation time of 20 minutes once a week delivered by an experienced Physiotherapist. In the last 10 minutes of each electrical nerve stimulation session women will be requested to perform voluntary PFM contractions along with the contractions induced by the electrical stimulation. Women will not be instructed to perform any aditional exercise or therapy at home.

Intervention

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women who are routinely referred to the Lucy Montoro Rehabilitation Center of the Hospital das Clínicas of the University of São Paulo at Ribeirão Preto Medical School - HCFMRP-USP for the physiotherapeutic treatment of pelvic floor dysfunctions;
  • Pelvic floor muscle function grade 0 (zero) or 1 evaluated by bidigital palpation (Modified Oxford Scale);
  • Consent to participate in the study and signing of the free and informed consent form.

You may not qualify if:

  • Women with associated neurological pathologies;
  • Symptoms of vaginal or urinary tract infection;
  • Prolapses classified above grade 2;
  • Suspected or confirmed pregnancy and cognitive deficit that compromises the procedure.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto

Ribeirão Preto, São Paulo, 14620000, Brazil

Location

Related Publications (1)

  • Ignacio Antonio F, Bo K, Pena CC, Bueno SM, Mateus-Vasconcelos ECL, Fernandes ACNL, Ferreira CHJ. Intravaginal electrical stimulation increases voluntarily pelvic floor muscle contractions in women who are unable to voluntarily contract their pelvic floor muscles: a randomised trial. J Physiother. 2022 Jan;68(1):37-42. doi: 10.1016/j.jphys.2021.12.004. Epub 2021 Dec 21.

Study Officials

  • Cristine HJ Ferreira, PhD

    Ribeirão Preto Medical School, University of São Paulo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The main investigators and assessor will be blinded in relation to the allocation of participants in the groups
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 19, 2017

First Posted

October 24, 2017

Study Start

December 12, 2017

Primary Completion

March 6, 2020

Study Completion

March 6, 2020

Last Updated

June 18, 2020

Record last verified: 2020-06

Locations